To determine whether LPPC/TAM could enhance the cytotoxicity of TAM in different types of breast cancer cells, such as ER-positive MCF-7 and BT474 cells and ER-negative MDA-MB-231 cells were analyzed by MTT assay. Here, ESR1 is linked to breast carcinoma.